Merck ( Merck )


Merck's picture

About Merck

Merck Press Release and News

Merck press release, blog etc

10/17/2018 - 14:26 Merck Announces Appointment of Jim Scholefield as Chief Information and Digital Officer
10/16/2018 - 13:13 U.S. FDA Grants LYNPARZA (olaparib) Orphan Drug Designation for Pancreatic Cancer
10/10/2018 - 15:45 Merck to Hold Third-Quarter 2018 Sales and Earnings Conference Call on October 25
10/04/2018 - 17:33 Merck Acknowledges the U.S. Department of Veterans Affairs (VA) for Adopting Biosimilar Medicines to Increase Treatment Options for Veterans
10/04/2018 - 10:22 Mercks HIV Therapy DELSTRIGO (doravirine / lamivudine / tenofovir disoproxil fumarate) Meets Primary Efficacy Endpoint in Phase 3 DRIVE-SHIFT Study Evaluating Switch to DELSTRIGO from Other Antiretroviral Treatment Regimens
10/04/2018 - 09:15 Merck Announces Week 96 Data from Pivotal Phase 3 DRIVE-AHEAD Study Evaluating DELSTRIGO (doravirine / lamivudine / tenofovir disoproxil fumarate) for the Treatment of HIV-1 in Treatment-Naive Patients
10/01/2018 - 10:20 Merck Announces Safer Childbirth Cities Initiative, Issues Call to Action to Reverse the Rise in U.S. Maternal Deaths
09/26/2018 - 00:25 Merck Board Rescinds Mandatory CEO Retirement Policy
09/20/2018 - 02:15 Merck Receives Positive CHMP Opinion for DELSTRIGO (doravirine/lamivudine/tenofovir disoproxil fumarate) and PIFELTRO (doravirine) in the European Union for the Treatment of HIV-1 Infection
09/19/2018 - 23:22 Merck Publishes Corporate Responsibility Report
09/11/2018 - 17:38 Mercks ZERBAXA (ceftolozane and tazobactam) Met Primary Endpoints of Non-Inferiority Compared to Meropenem in Pivotal Phase 3 Study of Adult Patients with Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia
08/30/2018 - 19:41 FDA Approves Mercks DELSTRIGO (doravirine / lamivudine / tenofovir disoproxil fumarate), a Once-Daily Fixed-Dose Combination Tablet as a Complete Regimen and PIFELTRO (doravirine), an NNRTI, Both for the Treatment of HIV-1 in Appropriate Patients
08/17/2018 - 06:48 Healthy Interactions and Merck Announce Launch of Digital Health Platform Designed to Enhance Patient Engagement in Diabetes Management
08/15/2018 - 09:52 Merck Foundation Supports New Programs to Improve Care for Alzheimers Patients And Caregivers in the United States
08/07/2018 - 00:43 Mercks Head of Human Resources Mirian M. Graddick-Weir to Retire; Steven C. Mizell Will Assume Role on Oct. 1
08/01/2018 - 04:53 Merck Foundation and Marshall Health Announce New Initiative to Address Opioid Epidemic in West Virginia
07/24/2018 - 17:05 Merck Announces Week 96 Data from Pivotal Phase 3 DRIVE-FORWARD Study of Its Investigational HIV Therapy Doravirine
07/02/2018 - 04:58 LYNPARZA (olaparib) Approved in Japan for BRCA-Mutated Metastatic Breast Cancer